Correlation between DJ-1 levels in the cerebrospinal fluid and the progression of disabilities in multiple sclerosis

M Hirotani1, C Maita, M Niino

  • 1Department of Neurology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|July 18, 2008
PubMed
Abstract

Insights

Levels of DJ-1 protein in cerebrospinal fluid (CSF) are elevated in multiple sclerosis (MS) patients and correlate with disease severity. This suggests DJ-1 may play a role in MS pathogenesis.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Immunology

Background:

  • Oxidative stress is implicated in the pathogenesis of multiple sclerosis (MS).
  • DJ-1 is a protein involved in anti-oxidative stress functions.
  • Understanding the role of DJ-1 in MS is crucial for developing therapeutic strategies.

Purpose of the Study:

  • To investigate DJ-1 levels in patients with multiple sclerosis (MS).
  • To examine the association between DJ-1 levels and MS progression.

Main Methods:

  • Quantitative immunoblot assays were used to measure DJ-1 levels.
  • Samples included serum and cerebrospinal fluid (CSF) from MS patients, disease controls, and healthy controls.

Main Results:

  • Serum DJ-1 levels showed no significant difference across groups.
  • CSF DJ-1 levels were significantly higher in MS patients compared to disease controls (P < 0.0001).
  • CSF DJ-1 levels positively correlated with the Multiple Sclerosis Severity Score (P < 0.005, r = 0.501).

Conclusions:

  • CSF DJ-1 levels are elevated in MS patients.
  • Increased CSF DJ-1 levels are associated with MS disease progression.
  • DJ-1 may play a significant role in the pathogenesis of MS.